Navigation Links
New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
Date:11/19/2008

xperienced quantifiable objective improvement in the depths of acne scars that ranged from 43% to 79.9%, with a mean level of improvement of 66.8%.

"Overall, patients were highly satisfied with their outcomes, as well as with the reduced downtime and safety profile. No delayed onset of hypopigmentation or permanent scarring was observed," said Dr. Chapas. "Despite our small sample size, we did notice clinical trends in the patient's response to various treatment energies. For example, patients who received higher energy levels on deep scars of the cheeks during the second and third treatments received the highest improvement scores. All four of these patients showed average overall improvement in the 51%-75% range three months after their final treatment."

Although the study was designed using a series of treatments to improve acne scarring, Dr. Chapas noted that in her practice one treatment with CO2 ablative fractional resurfacing is usually sufficient to produce a noticeable improvement. "After we perform one treatment, we wait to see how the newly stimulated collagen fills in the scar over the course of the next few months to determine if an additional treatment is needed. The good news is that most patients rarely require a second treatment."

Dr. Chapas added that future studies are needed to address parameters in treating patients with darker skin, who are prone to pigmentation problems following ablative treatments. In the study, the darkest skin types treated were Asian and lighter Hispanic patients.

The American Society for Laser Medicine and Surgery (ASLMS) is the world's preeminent resource for laser research, safety, education, and clinical knowledge. Founded in 1980, ASLMS promotes excellence in patient care by advancing clinical application of lasers and related technologies. For more information and physician referrals, visit

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 1DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 2DNA Genotek Sample Collection Kit Selected by Prometheus for MyCeliacID 26amp 3B 238482 3B Genetic Test 13611 3Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 1Indoor Tanning Association Opposes Suffolk Bill Banning Teens From Sun Beds 54741 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 1Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 2Union HealthShare Signs Multi Year Multi Million Dollar Agreement with North Star Health 54736 3